Phenotypical and functional study of ghrelin and its receptor in the pathogenesis of Crohn's disease

Inflammatory Bowel Diseases

Volumn 14, Issue 9, 2008, Pages 1205-1213

  Hosomi, Shuhei ^a   Oshitani, Nobuhide ^a   Kamata, Noriko ^a   Sogawa, Mitsue ^a   Yamagami, Hirokazu ^a   Watanabe, Kenji ^a   Tominaga, Kazunari ^a   Watanabe, Toshio ^a   Fujiwara, Yasuhiro ^a   Maeda, Kiyoshi ^a   Hirakawa, Kosei ^a   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Crohn's disease; Ghrelin; Growth hormone secretagogue receptor; Inflammatory bowel disease

Indexed keywords

AZATHIOPRINE; CD3 ANTIGEN; CD68 ANTIGEN; GAMMA INTERFERON; GHRELIN; GROWTH HORMONE SECRETAGOGUE RECEPTOR; GROWTH HORMONE SECRETAGOGUE RECEPTOR 1A; INFLIXIMAB; INTERLEUKIN 13; INTERLEUKIN 4; MESALAZINE; MESSENGER RNA; SULFAPYRIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTAPHERESIS; ENTERITIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DYSREGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; IMMUNOREGULATION; INTESTINE BIOPSY; INTESTINE RESECTION; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; ULCERATIVE COLITIS;

ADULT; AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; FEMALE; FLOW CYTOMETRY; GHRELIN; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-4; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, GHRELIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 54349104242     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20477     Document Type: Article

References (36)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
2. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660.
3. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194-198.
4. Tesauro M, Schinzari F, Iantorno M, et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation. 2005;112: 2986-2992.
5. Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276: 905-908.
6. Tack J, Depoortere I, Bisschops R, et al. Influence of ghrelin on inter-digestive gastrointestinal motility in humans. Gut. 2006;55:327-333.
7. Konturek PC, Brzozowski T, Pajdo R, et al. Ghrelin - a new gastro-protective factor in gastric mucosa. J Physiol Pharmacol. 2004;55:325-336.
8. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001;86: 4753-4758.
9. Korbonits M, Kojima M, Kangawa K, et al, Presence of ghrelin in normal and adenomatous human pituitary. Endocrine. 2001;14:101-104.
10. Korbonits M, Bustin SA, Kojima M, et al. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab. 2001;86:881-887.
11. Volante M, Allia E, Gugliotta P, et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab. 2002;87:1300-1308.
12. Volante M, Fulcheri E, Allia E, et al. Ghrelin expression in fetal, infant, and adult human lung. J Histochem Cytochem. 2002;50:1013-1021.
13. Cummings DE, Purnell JQ, Frayo RS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714-1719.
14. Tschop M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707-709.
15. Ghigo E, Broglio F, Arvat E, et al. Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor. Clin Endocrinol. 2005;62:1-17.
16. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002;87:2988-2991.
17. Chang L, Du JB, Gao LR, et al. Effect of ghrelin on septic shock in rats. Acta Pharmacol Sin. 2003;24:45-49.
18. Granado M, Priego T, Martin AI, et al. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am J Physiol Endocrinol Metab. 2005;288:E486-E492.
19. Peracchi M, Conte D, Terrani C, et al. Circulating ghrelin levels in celiac patients. Am J Gastroenterol. 2003;98:2474-2478.
20. Peracchi M, Bardella MT, Caprioli F, et al. Circulating ghrelin levels in patients with inflammatory bowel disease. Gut. 2006;55:432-433.
21. Otero M, Nogueiras R, Lago F, et al. Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology. 2004;43:306-310.
22. Hattori N, Saito T, Yagyu T, et al. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab. 2001;86:4284-4291.
23. Dixit VD, Schaffer EM, Pyle RS, et al. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 2004;114:57-66.
24. Li WG, Gavrila D, Liu XB, et al. Ghrelin inhibits proinflammatory responses and nuclear factor-kappa B activation in human endothelial cells. Circulation. 2004;109:2221-2226.
25. Gonzalez-Rey E, Chorny A, Delgado M. Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology. 2006;130:1707-1720.
26. Gonzalez-Rey E, Chorny A, Del Moral RG, et al. Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses. Ann Rheum Dis. 2007;66:582-588.
27. Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007;133:412-422.
28. Best W, Becktel J, Singleton J, et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976;70:439-444.
29. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative-colitis - a randomized study. N Engl J Med. 1987;317:1625-1629.
30. Kineman RD, Kamegai J, Frohman LA. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. Endocrinology. 1999;140:3581-3586.
31. Tamura H, Kamegai J, Sugihara H, et al. Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression. J Neuroendocrinol. 2000;12:481-485.
32. Karmiris K, Koutroubakis JE, Xidakis C, et al. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:100-105.
33. Dass NB, Munonyara M, Bassil AK, et al. Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin. Neuroscience. 2003;120:443-453.
34. Takeshita E, Matsuura B, Dong MQ, et al. Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol. 2006;41:223-230.
35. Maul J, Loddenkemper C, Mundt P, et al. Peripheral and intestinal regulatory CD4+CD25(high) T cells in inflammatory bowel disease. Gastroenterology. 2005;128:1868-1878.
36. Schottelius A, Wedel S, Weltrich R, et al. Higher expression of glucocorticoid receptor in peripheral mononuclear cells in inflammatory bowel disease. Am J Gastroenterol. 2000;95:1994-1999.